146 related articles for article (PubMed ID: 8286012)
21. Synthesis of new 4-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]quinoxaline and 5-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitors.
Vidaillac C; Guillon J; Moreau S; Arpin C; Lagardère A; Larrouture S; Dallemagne P; Caignard DH; Quentin C; Jarry C
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):620-31. PubMed ID: 18035830
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins.
Denny WA; Atwell GJ; Roberts PB; Anderson RF; Boyd M; Lock CJ; Wilson WR
J Med Chem; 1992 Dec; 35(26):4832-41. PubMed ID: 1479583
[TBL] [Abstract][Full Text] [Related]
23. Hypoxic cells in tumors as a target for cancer therapy.
Gali-Muhtasib HU; Diab-Assef M; Haddadin MJ
J Med Liban; 2002; 50(4):175-9. PubMed ID: 15298478
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells.
Palmer BD; Wilson WR; Cliffe S; Denny WA
J Med Chem; 1992 Aug; 35(17):3214-22. PubMed ID: 1507207
[TBL] [Abstract][Full Text] [Related]
26. Radical Chemistry and Cytotoxicity of Bioreductive 3-Substituted Quinoxaline Di-N-Oxides.
Anderson RF; Yadav P; Shinde SS; Hong CR; Pullen SM; Reynisson J; Wilson WR; Hay MP
Chem Res Toxicol; 2016 Aug; 29(8):1310-24. PubMed ID: 27380897
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
Tercel M; Wilson WR; Anderson RF; Denny WA
J Med Chem; 1996 Mar; 39(5):1084-94. PubMed ID: 8676343
[TBL] [Abstract][Full Text] [Related]
28. Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity.
Vitale G; Corona P; Loriga M; Paglietti G
Farmaco; 1998; 53(8-9):594-601. PubMed ID: 10081824
[TBL] [Abstract][Full Text] [Related]
29. Effective synthesis of benzimidazoles-imidazo[1,2-a]pyrazine conjugates: A comparative study of mono-and bis-benzimidazoles for antitumor activity.
Singh I; Luxami V; Paul K
Eur J Med Chem; 2019 Oct; 180():546-561. PubMed ID: 31344614
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.
Solano B; Junnotula V; Marín A; Villar R; Burguete A; Vicente E; Pérez-Silanes S; Aldana I; Monge A; Dutta S; Sarkar U; Gates KS
J Med Chem; 2007 Nov; 50(22):5485-92. PubMed ID: 17910426
[TBL] [Abstract][Full Text] [Related]
31. Emergence of pyrido quinoxalines as new family of antimalarial agents.
Chandra Shekhar A; Shanthan Rao P; Narsaiah B; Allanki AD; Sijwali PS
Eur J Med Chem; 2014 Apr; 77():280-7. PubMed ID: 24650715
[TBL] [Abstract][Full Text] [Related]
32. 2-Cyclopropylindoloquinones and their analogues as bioreductively activated antitumor agents: structure-activity in vitro and efficacy in vivo.
Naylor MA; Jaffar M; Nolan J; Stephens MA; Butler S; Patel KB; Everett SA; Adams GE; Stratford IJ
J Med Chem; 1997 Jul; 40(15):2335-46. PubMed ID: 9240349
[TBL] [Abstract][Full Text] [Related]
33. Facile synthesis of C6-substituted benz[4,5]imidazo[1,2-a]quinoxaline derivatives and their anticancer evaluation.
Singh R; Kumar R; Pandrala M; Kaur P; Gupta S; Tailor D; Malhotra SV; Salunke DB
Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000393. PubMed ID: 33749032
[TBL] [Abstract][Full Text] [Related]
34. Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitro.
Naylor MA; Swann E; Everett SA; Jaffar M; Nolan J; Robertson N; Lockyer SD; Patel KB; Dennis MF; Stratford MR; Wardman P; Adams GE; Moody CJ; Stratford IJ
J Med Chem; 1998 Jul; 41(15):2720-31. PubMed ID: 9667963
[TBL] [Abstract][Full Text] [Related]
35. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.
Moarbess G; Deleuze-Masquefa C; Bonnard V; Gayraud-Paniagua S; Vidal JR; Bressolle F; Pinguet F; Bonnet PA
Bioorg Med Chem; 2008 Jul; 16(13):6601-10. PubMed ID: 18513976
[TBL] [Abstract][Full Text] [Related]
37. Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.
Patterson LH
Cancer Metastasis Rev; 1993 Jun; 12(2):119-34. PubMed ID: 8375016
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
Tercel M; Lee AE; Hogg A; Anderson RF; Lee HH; Siim BG; Denny WA; Wilson WR
J Med Chem; 2001 Oct; 44(21):3511-22. PubMed ID: 11585455
[TBL] [Abstract][Full Text] [Related]
39. Metabolic and radiolytic reduction of 4-alkylamino-5-nitroquinoline bioreductive drugs. Relationship to hypoxia-selective cytotoxicity.
Siim BG; Atwell GJ; Wilson WR
Biochem Pharmacol; 1994 Oct; 48(8):1593-604. PubMed ID: 7980625
[TBL] [Abstract][Full Text] [Related]
40. Nitro analogues of chlorambucil as potential hypoxia-selective anti-tumour drugs.
Palmer BD; Wilson WR; Denny WA
Anticancer Drug Des; 1990 Nov; 5(4):337-49. PubMed ID: 2291774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
